Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Withdrawn 1Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 3Sarcoma 1

Conditions

Leukemia, Myeloid, Acute 82Myelodysplastic Syndromes 71Precursor Cell Lymphoblastic Leukemia-Lymphoma 69Leukemia, Lymphocytic, Chronic, B-Cell 69Lymphoma, Non-Hodgkin 63Hodgkin Disease 62Leukemia 56Multiple Myeloma 52Lymphoma 46Lymphoma, Follicular 44Lymphoma, Mantle-Cell 41Leukemia, Myelogenous, Chronic, BCR-ABL Positive 41Lymphoma, Large B-Cell, Diffuse 40Lymphoma, B-Cell, Marginal Zone 39Myeloproliferative Disorders 36Burkitt Lymphoma 35Congenital Abnormalities 29Lymphoma, Large-Cell, Immunoblastic 27Leukemia, Myelomonocytic, Chronic 27Hematologic Neoplasms 27Leukemia, Myeloid, Chronic-Phase 26Waldenstrom Macroglobulinemia 22Neoplasms, Plasma Cell 22Leukemia, Myeloid, Accelerated Phase 22Anemia, Refractory, with Excess of Blasts 22Graft vs Host Disease 21Primary Myelofibrosis 20Recurrence 19Leukemia, Prolymphocytic 19Dendritic Cell Sarcoma, Interdigitating 18

Interventions

Cyclophosphamide 34Etoposide 25Doxorubicin 20Carboplatin 20Vincristine 19Isotretinoin 19Topotecan 17Temozolomide 17Irinotecan 16Filgrastim 16Melphalan 15Cisplatin 15sargramostim 14Radiotherapy 14Granulocyte-Macrophage Colony-Stimulating Factor 133-Iodobenzylguanidine 12dinutuximab 11Peripheral Blood Stem Cell Transplantation 11naxitamab 9Thiotepa 9Magnetic Resonance Spectroscopy 9humanized 3F8 anti-GD2 monoclonal antibody 7Granulocyte Colony-Stimulating Factor 7Busulfan 7X-Rays 6Specimen Handling 6Phantoms, Imaging 6Ifosfamide 6Antilymphocyte Serum 6fludarabine phosphate 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Neuroblastoma × Mycophenolic Acid × Clear all
NCT04530487 2025-06-29

Donor Stem Cell Transplant After Chemotherapy for the Treatment of Recurrent or Refractory High-Risk Solid Tumors in Pediatric and Adolescent-Young Adults

M.D. Anderson Cancer Center

Phase 2 Terminated
1 enrolled 7 charts
CNSSarcoma

Neuroblastoma, Rhabdomyosarcoma, Neuroectodermal Tumors, Primitive, Peripheral, Neurofibrosarcoma, Desmoplastic Small Round Cell Tumor

NCT05303727 2022-07-01

Allogeneic Hematopoietic Stem Cell Transplantation for 4/M Neuroblastoma

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 2 Not yet recruiting
64 enrolled
CNS

Neuroblastoma

NCT00874315 2015-10-16

Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Refractory High-Risk NBL.

Nationwide Children's Hospital

Phase 2 Withdrawn
CNS

Neuroblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡